West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
337.47
-8.62 (-2.49%)
At close: Aug 28, 2026, 4:00 PM EDT
337.47
0.00 (0.00%)
After-hours: Aug 28, 2026, 4:20 PM EDT

WST Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
564.9493.7492.7593.4585.9661.8
Depreciation & Amortization
181.4171.4155.4137.3120.6122.3
Loss (Gain) From Sale of Assets
---11.6--
Asset Writedown & Restructuring Costs
17.517.17.39.621.55.6
Loss (Gain) on Equity Investments
-10.5-10.5-13.4-14.3-18.1-17.4
Stock-Based Compensation
32.623.818.723.323.737.5
Other Operating Activities
-18.6-20.5-10.2365.4-27.7
Change in Accounts Receivable
6.96.9-58.84-35.6-123.5
Change in Inventory
-62.8-62.842-13.5-49.8-86.5
Change in Accounts Payable
17.917.92.94.4-2.816.8
Change in Other Net Operating Assets
-67.1117.816.8-15.373.2-4.9
Operating Cash Flow
662.2754.8653.4776.5724584
Operating Cash Flow Growth
-2.14%15.52%-15.85%7.25%23.97%23.60%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-225.3-285.9-377-362-284.6-253.4
Cash Acquisitions
------2.2
Other Investing Activities
---1.7-6.7-3.62.5
Investing Cash Flow
-225.3-285.9-378.7-368.7-288.2-253.1

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--164.7---
Total Debt Issued
50-164.7---
Long-Term Debt Repaid
--1.1-192.3-2.4-44.3-2.2
Total Debt Repaid
-51.3-1.1-192.3-2.4-44.3-2.2
Net Debt Issued (Repaid)
-1.3-1.1-27.6-2.4-44.3-2.2
Issuance of Common Stock
24.918.232.75128.237.1
Repurchase of Common Stock
-457.1-136.8-566.6-451.2-222.2-151.9
Common Dividends Paid
-62.4-61.2-59.1-57-54.1-51.1
Other Financing Activities
-0.8-4.2-2--1.2-
Financing Cash Flow
-496.7-185.1-622.6-459.6-293.6-168.1

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-14.122.9-21.411.4-10.5-15.7
Net Cash Flow
-73.9306.7-369.3-40.4131.7147.1

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
436.9468.9276.4414.5439.4330.6
Free Cash Flow Growth
27.01%69.64%-33.32%-5.67%32.91%10.90%
Free Cash Flow Margin
13.13%15.25%9.55%14.05%15.22%11.68%
Free Cash Flow Per Share
6.056.453.755.505.804.33
Levered Free Cash Flow
277.94273.88206.73196.35246.54210.05
Unlevered Free Cash Flow
280.75274.19208.6201.98251.48215.18

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.30.30.566.68
Cash Income Tax Paid
125.2125.271.490.8109.7171.8
Change in Working Capital
-105.179.82.9-20.4-15-198.1
SEC Filings: 10-K · 10-Q